Squarepoint Ops LLC Raises Stake in Phreesia, Inc. (NYSE:PHR)

Squarepoint Ops LLC increased its stake in shares of Phreesia, Inc. (NYSE:PHR) by 56.3% during the second quarter, HoldingsChannel.com reports. The firm owned 250,396 shares of the company’s stock after buying an additional 90,215 shares during the period. Squarepoint Ops LLC’s holdings in Phreesia were worth $5,308,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in PHR. Vanguard Group Inc. raised its holdings in shares of Phreesia by 4.4% in the 4th quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock valued at $107,148,000 after acquiring an additional 194,035 shares in the last quarter. Champlain Investment Partners LLC purchased a new stake in shares of Phreesia in the 1st quarter valued at about $29,941,000. Boston Partners purchased a new stake in shares of Phreesia in the 1st quarter valued at about $669,000. Blair William & Co. IL raised its holdings in shares of Phreesia by 42.6% in the 1st quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock valued at $18,012,000 after acquiring an additional 224,950 shares in the last quarter. Finally, Russell Investments Group Ltd. raised its holdings in shares of Phreesia by 1,407.9% in the 1st quarter. Russell Investments Group Ltd. now owns 57,874 shares of the company’s stock valued at $1,385,000 after acquiring an additional 54,036 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. DA Davidson reaffirmed a “buy” rating and issued a $32.00 price target on shares of Phreesia in a report on Thursday, September 5th. Robert W. Baird raised their price objective on Phreesia from $31.00 to $34.00 and gave the company an “outperform” rating in a report on Friday, September 6th. JPMorgan Chase & Co. raised their price objective on Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Monday, September 9th. JMP Securities reissued a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a report on Thursday, September 5th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $23.00 price objective on shares of Phreesia in a report on Friday. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $29.42.

Insider Buying and Selling

In related news, CFO Balaji Gandhi sold 3,502 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total transaction of $81,421.50. Following the transaction, the chief financial officer now directly owns 98,578 shares in the company, valued at approximately $2,291,938.50. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, CFO Balaji Gandhi sold 3,502 shares of Phreesia stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $81,421.50. Following the sale, the chief financial officer now directly owns 98,578 shares in the company, valued at approximately $2,291,938.50. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Chaim Indig sold 2,644 shares of Phreesia stock in a transaction that occurred on Tuesday, July 16th. The stock was sold at an average price of $23.74, for a total value of $62,768.56. Following the completion of the sale, the chief executive officer now owns 1,219,361 shares in the company, valued at $28,947,630.14. The disclosure for this sale can be found here. Insiders have sold a total of 46,203 shares of company stock worth $1,129,699 in the last ninety days. 5.80% of the stock is owned by insiders.

Phreesia Price Performance

PHR opened at $22.79 on Tuesday. The stock’s 50 day simple moving average is $24.01 and its 200 day simple moving average is $22.63. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.77 and a quick ratio of 1.77. Phreesia, Inc. has a 1 year low of $12.05 and a 1 year high of $29.16. The firm has a market cap of $1.32 billion, a price-to-earnings ratio of -10.50 and a beta of 0.93.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Wednesday, September 4th. The company reported ($0.31) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.37) by $0.06. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. The business had revenue of $102.12 million for the quarter, compared to analyst estimates of $101.76 million. As a group, analysts predict that Phreesia, Inc. will post -1.23 earnings per share for the current year.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.